iRhythm Technologies (IRTC)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.59 (+1.93%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of iRhythm Technologies (IRTC)
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $84.28
  • Market Cap

    $2.64 Billion
  • Total Outstanding Shares

    31.30 Million Shares
  • Total Employees

    2,000
  • Dividend

    No dividend
  • IPO Date

    October 20, 2016
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.irhythmtech.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities$-35,000.00
Net Cash Flow From Investing Activities, Continuing$-55.33 Million
Net Cash Flow From Financing Activities, Continuing$-35,000.00
Net Cash Flow From Operating Activities, Continuing$24.35 Million
Net Cash Flow$-31.02 Million
Net Cash Flow From Investing Activities$-55.33 Million
Net Cash Flow From Operating Activities$24.35 Million
Net Cash Flow, Continuing$-31.02 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Basic Average Shares$31.26 Million
Income/Loss From Continuing Operations After Tax$-46.18 Million
Preferred Stock Dividends And Other Adjustments$0.00
Costs And Expenses$193.53 Million
Diluted Average Shares$31.26 Million
Selling, General, and Administrative Expenses$103.38 Million
Income Tax Expense/Benefit$188,000.00
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Basic Earnings Per Share$-1.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Available To Common Stockholders, Basic$-46.18 Million
Nonoperating Income/Loss$4.31 Million
Revenues$147.54 Million
Gross Profit$101.48 Million
Diluted Earnings Per Share$-1.48
Operating Expenses$151.78 Million
Net Income/Loss Attributable To Parent$-46.18 Million
Net Income/Loss$-46.18 Million
Benefits Costs and Expenses$193.53 Million
Cost Of Revenue$46.06 Million
Other Operating Expenses$48.40 Million
Depreciation and Amortization$5.13 Million
Income/Loss From Continuing Operations Before Tax$-45.99 Million
Operating Income/Loss$-50.30 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Equity Attributable To Parent$71.77 Million
Assets$909.69 Million
Liabilities And Equity$909.69 Million
Cash$165.46 Million
Inventory$15.03 Million
Accounts Payable$7.59 Million
Other Current Liabilities$92.51 Million
Equity Attributable To Noncontrolling Interest$0.00
Current Assets$627.91 Million
Fixed Assets$122.39 Million
Other Non-current Assets$159.39 Million
Current Liabilities$100.10 Million
Noncurrent Liabilities$737.82 Million
Equity$71.77 Million
Liabilities$837.92 Million
Other Current Assets$447.41 Million
Noncurrent Assets$281.78 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.